Your account is not claimed yet. You can sign up with ORCID to claim your account.

Pierre P Roger

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Breast Cancer Cells

Gas Chromatography

Tyrosine Kinase

Capillary Electrophoresis

Top Venues

EMBO molecular medicine

Journal of the American Chemical Society

Université Libre de Bruxelles (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Université Libre de Bruxelles Aug 31o 1984

Belgium

PHD :: Institute of Interdisciplinary Research (IRIBHM)

Publications

Tatjana Arsenijevic, Katia Coulonval, Eric Raspé, Anne Demols, Pierre P Roger, Jean-Luc Van Laethem
CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges. Cancers 15 (3) (2023)
Tatjana Arsenijevic, Katia Coulonval, Eric Raspé, Anne Demols, Pierre P Roger, Jean-Luc Van Laethem
CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges. Cancers 15 (3) (2023)
Angel Gonzalez-Valero, Audrey G Reeves, Annika C S Page, Patrick J Moon, Edward Miller, Katia Coulonval, Steven W M Crossley, Xiao Xie, Dan He, Patricia Z Musacchio, Alec H Christian, Jeffrey M McKenna, Richard A Lewis, Eric Fang, Dustin Dovala, Yipin Lu, Lynn M McGregor, Markus Schirle, John A Tallarico, Pierre P Roger, F Dean Toste, Christopher J Chang
An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4. Journal of the American Chemical Society (2022)
Eric Raspé, Katia Coulonval, Jaime M Pita, Sabine Paternot, Françoise Rothé, Laure Twyffels, Sylvain Brohée, Ligia Craciun, Denis Larsimont, Véronique Kruys, Flavienne Sandras, Isabelle Salmon, Steven Van Laere, Martine Piccart, Michail Ignatiadis, Christos Sotiriou, Pierre P Roger
CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclib. EMBO molecular medicine 9 (8) (2018)